Squadron Capital Management LLC 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Squadron Capital Management LLC disclosed 29 US equity positions worth $224.1m in its Q4 2025 13F filing. The largest position was RLMD at 14.4% of the reported book, followed by COGT and MAZE.
What did Squadron Capital Management LLC own in Q4 2025? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 14.4% | $32.4m | 6,700,000 | – | |
| 2 | COGT COGENT BIOSCIENCES INC | Healthcare | 12.4% | $27.7m | 780,000 | – | |
| 3 | MAZE MAZE THERAPEUTICS INC | 9.1% | $20.3m | 490,000 | – | ||
| 4 | ABVX ABIVAX SA | 8.7% | $19.6m | 145,000 | – | ||
| 5 | 4XC1 KALVISTA PHARMACEUTICALS INC | 5.0% | $11.3m | 700,000 | – | ||
| 6 | PALI PALISADE BIO INC | Healthcare | 4.7% | $10.6m | 4,500,000 | – | |
| 7 | EWTX EDGEWISE THERAPEUTICS INC | 3.9% | $8.7m | 350,000 | – | ||
| 8 | IKT INHIBIKASE THERAPEUTICS INC | 3.9% | $8.7m | 4,225,000 | – | ||
| 9 | KOD KODIAK SCIENCES INC | Healthcare | 3.6% | $8.2m | 291,710 | – | |
| 10 | 430 TERNS PHARMACEUTICALS INC | 3.4% | $7.7m | 190,000 | – | ||
| 11 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 2.9% | $6.6m | 80,000 | – | |
| 12 | UPB UPSTREAM BIO INC | 2.8% | $6.3m | 230,650 | – | ||
| 13 | SPRB SPRUCE BIOSCIENCES INC | 2.7% | $6.1m | 70,000 | – | ||
| 14 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.1% | $4.7m | 105,551 | – | |
| 15 | DBVT DBV TECHNOLOGIES S A | 2.1% | $4.6m | 240,000 | – | ||
| 16 | HELP CYBIN INC | 1.9% | $4.3m | 525,000 | – | ||
| 17 | LPCN LIPOCINE INC NEW | 1.9% | $4.3m | 530,000 | – | ||
| 18 | BLTE BELITE BIO INC | Healthcare | 1.9% | $4.2m | 26,000 | – | |
| 19 | GHRS GH RESEARCH PLC | 1.8% | $4.0m | 315,000 | – | ||
| 20 | EPRX EUPRAXIA PHARMACEUTICALS INC | 1.7% | $3.8m | 500,000 | – | ||
| 21 | VTYXUSD VENTYX BIOSCIENCES INC | 1.7% | $3.7m | 410,000 | – | ||
| 22 | NXTC NEXTCURE INC | 1.5% | $3.4m | 236,966 | – | ||
| 23 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 1.3% | $3.0m | 175,000 | – | |
| 24 | KTTA PASITHEA THERAPEUTICS CORP | 1.2% | $2.7m | 2,100,000 | – | ||
| 25 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.2% | $2.7m | 388,287 | – | |
| 26 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.1% | $2.4m | 130,000 | – | |
| 27 | IVA INVENTIVA SA | 0.6% | $1.4m | 300,000 | – | ||
| 28 | TRAW TRAWS PHARMA INC | 0.4% | $806.3k | 713,540 | – | ||
| 29 | CLYM CLIMB BIO INC | 0.2% | $400.0k | 100,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.